Jazz Pharmaceuticals (JAZZN) Q1 2025 Earnings Report
MX:JAZZN Q1 2025 EPS Results
- Actual EPS
- MXN 31.22
- Consensus EPS
- MXN 86.55
- Beat/Miss
- Missed by -MXN 55.33
- One Year Ago EPS
- MXN 49.80
MX:JAZZN Q1 2025 Revenue Results
- Actual Revenue
- MXN 16.68B
- Expected Revenue
- MXN 18.28B
- Beat/Miss
- Missed by -MXN 1.60B
- YoY Revenue Growth
- -0.46%
Earnings Announcement Details
- Quarter
- Q1 2025
- Date
- 05/06/2025
- Time
- After Close
- Conference Call
- Tuesday, May 6, 2025
MX:JAZZN Upcoming Earnings
Jazz Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q1 2025 Earnings Call Audio
MX:JAZZN Q1 2025 Earnings Call
0:00 / 0:00
Q1 2025 Earnings Slide Deck
Q1 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:JAZZN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | 128.15- | 123.38 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -75.18-72.09 | 151.06 | -147.72% (-223.16) | |
| Aug 03, 2026 | 2026 (Q2) | 114.74106.10 | -153.29 | 169.21% (+259.39) | |
| May 05, 2026 | 2026 (Q1) | 86.23117.80 | 31.22 | 277.38% (+86.59) | |
| Feb 24, 2026 | 2025 (Q4) | 121.11123.38 | 122.63 | 0.61% (+0.74) | |
| Nov 05, 2025 | 2025 (Q3) | 110.48151.06 | 122.82 | 23.00% (+28.24) | |
| Aug 05, 2025 | 2025 (Q2) | -141.33-153.29 | 98.48 | -255.66% (-251.77) | |
| May 06, 2025 | 2025 (Q1) | 86.5531.22 | 49.8 | -37.31% (-18.58) | |
| Feb 25, 2025 | 2024 (Q4) | 108.92122.63 | 93.28 | 31.47% (+29.36) | |
| Nov 06, 2024 | 2024 (Q3) | 102.16122.82 | 89.93 | 36.57% (+32.89) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
